NM_030928.4:c.915T>C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_030928.4(CDT1):​c.915T>C​(p.His305His) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.796 in 1,598,186 control chromosomes in the GnomAD database, including 508,881 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.84 ( 54038 hom., cov: 35)
Exomes 𝑓: 0.79 ( 454843 hom. )

Consequence

CDT1
NM_030928.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -4.92

Publications

27 publications found
Variant links:
Genes affected
CDT1 (HGNC:24576): (chromatin licensing and DNA replication factor 1) The protein encoded by this gene is involved in the formation of the pre-replication complex that is necessary for DNA replication. The encoded protein can bind geminin, which prevents replication and may function to prevent this protein from initiating replication at inappropriate origins. Phosphorylation of this protein by cyclin A-dependent kinases results in degradation of the protein. [provided by RefSeq, Mar 2011]
CDT1 Gene-Disease associations (from GenCC):
  • Meier-Gorlin syndrome 4
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P
  • Meier-Gorlin syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant 16-88806103-T-C is Benign according to our data. Variant chr16-88806103-T-C is described in ClinVar as Benign. ClinVar VariationId is 128683.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-4.92 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.951 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDT1NM_030928.4 linkc.915T>C p.His305His synonymous_variant Exon 6 of 10 ENST00000301019.9 NP_112190.2 Q9H211

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDT1ENST00000301019.9 linkc.915T>C p.His305His synonymous_variant Exon 6 of 10 1 NM_030928.4 ENSP00000301019.4 Q9H211
CDT1ENST00000569140.1 linkc.183T>C p.His61His synonymous_variant Exon 2 of 5 3 ENSP00000456926.1 H3BSY1
CDT1ENST00000562747.1 linkn.621T>C non_coding_transcript_exon_variant Exon 5 of 5 2

Frequencies

GnomAD3 genomes
AF:
0.839
AC:
127616
AN:
152128
Hom.:
53983
Cov.:
35
show subpopulations
Gnomad AFR
AF:
0.959
Gnomad AMI
AF:
0.858
Gnomad AMR
AF:
0.769
Gnomad ASJ
AF:
0.868
Gnomad EAS
AF:
0.899
Gnomad SAS
AF:
0.857
Gnomad FIN
AF:
0.750
Gnomad MID
AF:
0.870
Gnomad NFE
AF:
0.788
Gnomad OTH
AF:
0.832
GnomAD2 exomes
AF:
0.801
AC:
181848
AN:
227080
AF XY:
0.804
show subpopulations
Gnomad AFR exome
AF:
0.962
Gnomad AMR exome
AF:
0.679
Gnomad ASJ exome
AF:
0.866
Gnomad EAS exome
AF:
0.896
Gnomad FIN exome
AF:
0.741
Gnomad NFE exome
AF:
0.790
Gnomad OTH exome
AF:
0.801
GnomAD4 exome
AF:
0.792
AC:
1144914
AN:
1445940
Hom.:
454843
Cov.:
55
AF XY:
0.794
AC XY:
570749
AN XY:
718954
show subpopulations
African (AFR)
AF:
0.968
AC:
32321
AN:
33388
American (AMR)
AF:
0.694
AC:
30281
AN:
43606
Ashkenazi Jewish (ASJ)
AF:
0.868
AC:
22537
AN:
25952
East Asian (EAS)
AF:
0.888
AC:
35012
AN:
39408
South Asian (SAS)
AF:
0.846
AC:
71929
AN:
85046
European-Finnish (FIN)
AF:
0.753
AC:
33338
AN:
44272
Middle Eastern (MID)
AF:
0.846
AC:
4867
AN:
5752
European-Non Finnish (NFE)
AF:
0.781
AC:
866181
AN:
1108496
Other (OTH)
AF:
0.807
AC:
48448
AN:
60020
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
14136
28272
42409
56545
70681
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20574
41148
61722
82296
102870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.839
AC:
127726
AN:
152246
Hom.:
54038
Cov.:
35
AF XY:
0.835
AC XY:
62185
AN XY:
74430
show subpopulations
African (AFR)
AF:
0.959
AC:
39866
AN:
41582
American (AMR)
AF:
0.769
AC:
11762
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.868
AC:
3013
AN:
3472
East Asian (EAS)
AF:
0.899
AC:
4655
AN:
5178
South Asian (SAS)
AF:
0.859
AC:
4145
AN:
4828
European-Finnish (FIN)
AF:
0.750
AC:
7936
AN:
10582
Middle Eastern (MID)
AF:
0.867
AC:
255
AN:
294
European-Non Finnish (NFE)
AF:
0.788
AC:
53559
AN:
67988
Other (OTH)
AF:
0.831
AC:
1756
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1085
2170
3256
4341
5426
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
884
1768
2652
3536
4420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.808
Hom.:
87922
Bravo
AF:
0.844
Asia WGS
AF:
0.869
AC:
3023
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 05, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Meier-Gorlin syndrome 4 Benign:2
Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
0.014
DANN
Benign
0.39
PhyloP100
-4.9
PromoterAI
0.037
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs510862; hg19: chr16-88872511; COSMIC: COSV56347265; COSMIC: COSV56347265; API